2-[2-[[5-(1-aminoisoquinolin-7-yl)-2-(oxolan-3-yl)indazol-3-yl]methoxy]-4-methoxyphenyl]acetic acid
C30H28N4O5 — CID 170559661
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[2-[[5-(1-aminoisoquinolin-7-yl)-2-(oxolan-3-yl)indazol-3-yl]methoxy]-4-methoxyphenyl]acetic acid
2-[2-[[5-(1-aminoisoquinolin-7-yl)-2-(oxolan-3-yl)indazol-3-yl]methoxy]-4-methoxyphenyl]acetic acid (PubChem CID 170559661) has the molecular formula C30H28N4O5 and a molecular weight of 524.58 g/mol. Its IUPAC name is 2-[2-[[5-(1-aminoisoquinolin-7-yl)-2-(oxolan-3-yl)indazol-3-yl]methoxy]-4-methoxyphenyl]acetic acid.
Molecular Properties
| Compound Name | 2-[2-[[5-(1-aminoisoquinolin-7-yl)-2-(oxolan-3-yl)indazol-3-yl]methoxy]-4-methoxyphenyl]acetic acid |
|---|---|
| PubChem CID | 170559661 |
| Molecular Formula | C30H28N4O5 |
| Molecular Weight | 524.58 g/mol |
| Exact Mass | 524.21 |
| IUPAC Name | 2-[2-[[5-(1-aminoisoquinolin-7-yl)-2-(oxolan-3-yl)indazol-3-yl]methoxy]-4-methoxyphenyl]acetic acid |
| SMILES | COc1ccc(CC(=O)O)c(OCc2c3cc(-c4ccc5ccnc(N)c5c4)ccc3nn2C2CCOC2)c1 |
| InChI | InChI=1S/C30H28N4O5/c1-37-23-6-4-21(14-29(35)36)28(15-23)39-17-27-25-13-20(5-7-26(25)33-34(27)22-9-11-38-16-22)19-3-2-18-8-10-32-30(31)24(18)12-19/h2-8,10,12-13,15,22H,9,11,14,16-17H2,1H3,(H2,31,32)(H,35,36) |
| InChIKey | LZZFHLVQABAYLO-UHFFFAOYSA-N |
| XLogP | 5.01 |
| TPSA | 121.72 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 39 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 524.58 |
| LogP ≤ 5 | 5.01 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 170559661 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.